
Vitality · Peptide Profile
A dual GIP/GLP-1 agonist delivering potent glycemic control and weight management.
Tirzepatide is a dual agonist of the GIP and GLP-1 receptors, representing the forefront of peptide-based metabolic therapy. It delivers potent glycemic control and significant weight management, and is among the most in-demand peptides worldwide.
Technical Profile
Size
10 mg
Purity
99%+
Backed by Research
Dual GIP/GLP-1 agonism
Potent glycemic control
Cutting-edge weight management
10 mg — $110 USD · $125 CAD · ₡55,000 CRC · 20 mg — $180 USD · $210 CAD · ₡90,000 CRC
Research Use Notice
All products are sold solely for legitimate in vitro laboratory research purposes. They are not intended for human consumption, animal use, therapeutic use, cosmetic use, dietary supplementation, or diagnostic purposes. Statements regarding these products have not been evaluated by the FDA.